8:30 – 9:00

Welcome/Opening

Dr. Paul Pearlman,
National Cancer Institute, NIH
Dr. Kimryn Rathmell, Director, National Cancer Institute (TBD)

9:00 – 9:30

Keynote Speaker

Invited: Stay tuned for updates!

Future of diagnostics in global health. Needs. Opportunities. Emerging platforms/technologies.

9:30 – 11:00

Panel 1: Designing for Impact

This panel will discuss best practices, approaches, and practical examples of technologies designed for enduring impact. The discussion will include, but is not limited to, design for end-use settings and building infrastructure; cultural differences and acceptability; and developing human capacity.

11:00 – 11:15

Break

11:15 – 12:00

Federal/NIH Resource Session: Funding for translational technology research.

This will be a panel of program staff who can speak to sources of federal funding for global health technology research.

12:00 – 12:45

Lunch and Networking

12:45 – 2:15

Panel 2: Future directions in global health technology research – The Next Generation of Point of Care Technologies

This panel will discuss technologies enabling cancer care at the point of need in LMICs.  Specific examples from past and current ACTs projects will be highlighted as well as emerging platforms that can be leveraged in the future.

2:15 – 2:30

Break

2:30 – 4:00

Panel 3: Cervical Cancer

This panel will highlight successful translation of enabling technologies for cervical cancer control spanning the goals covered in the WHO Cervical Cancer Elimination Initiative as well as where we are still falling short as a field.

4:00 – 4:30

Rapid Pitch Session

This panel will include rapid “pitch style” presentations for each project/technology included in the subsequent technology showcase.

4:30 – 5:30

Technology Showcase

Showcase of emerging technologies from past and current ACTs grantees as well as investigators supported by other NIH programs.

8:30 – 8:45

Welcome

8:45 – 9:15

Keynote Speaker
Dr. Somesh Kumar,
Senior Director, New Initiatives and Innovations, Jhpiego

Design and implementation of health technologies in the context of health systems. Intersection of technology development with policy/process.

9:15 – 10:45

Panel 4: Reciprocal Innovation

This panel will explore ways in which global health reciprocal innovation can enhance the impact and spread of health technologies, methodologies and strategies researched and developed in low- and middle-income countries (LMICs) to address similar health and health related challenges in different geographic locations and contexts, especially in high-income countries (HICs).

10:45 – 11:15

Rapid Pitch Session

This panel will include rapid “pitch style” presentations for each project/technology included in the subsequent technology showcase.

11:15 – 12:15

Technology Showcase

Showcase of emerging technologies from past and current ACTs grantees as well as investigators supported by other NIH programs.

12:15 – 1:00

Lunch and Networking

1:00 – 2:15

Panel 5: Regulatory and Commercialization

This panel will explore pathways to market. The session will include perspectives on investor engagement, industry engagement, and approaches to regulatory.

2:15 – 3:30

Small-Business Experiences

This panel will feature leaders from NCI-supported small businesses conducting commercial-driven research for global oncology.  Discussion will build on the pathways to market discussions from the previous panel and highlight the specific opportunities and challenges faced by small businesses in this domain.

3:30 – 3:45

Break

3:45 – 5:15

Panel 6: Future directions in global health technology research – Artificial Intelligence

This panel will focus on emerging issues in the development, validation, and implementation of AI models for global oncology, with a particular focus on ethical, legal, and social implications of new AI interventions as well as articulating key research questions and application areas the field should be pursuing.

5:15 – 5:30

Closing Remarks

Dr. Paul Pearlman, National Cancer Institute, NIH
Dr. Satish Gopal, Director, Center for Global Health, NCI